203
Views
14
CrossRef citations to date
0
Altmetric
Review

The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer

Pages 1-10 | Published online: 31 Dec 2012

References

  • De MarzoAMCoffeyDSNelsonWGNew concepts in tissue specificity for prostate cancer and benign prostatic hyperplasiaUrology1999533 Suppl 3a293910094098
  • McVaryKTBPH: epidemiology and comorbiditiesAm J Manag Care200612Suppl 5S122S12816613526
  • FitzpatrickJMThe natural history of benign prostatic hyperplasiaBJU Int200697Suppl 23616507045
  • FitzpatrickJMKirbyRSManagement of acute urinary retentionBJU Int200697Suppl 2162016507048
  • RoehrbornCGPathology of benign prostatic hyperplasiaInt J Impot Res200820Suppl 3S11S1819002119
  • SiegelRNaishadhamDJemalACancer statistics, 2012CA Cancer J Clin2012621102922237781
  • AlcarazAHammererPTubaroAScroderFHCastroRIs there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature reviewEur Urol200955486487319027219
  • McNealJENormal histology of the prostateAm J Surg Pathol19881286196332456702
  • McNealJENormal anatomy of the prostate and changes in benign prostatic hypertrophy and carcinomaSemin Ultrasound CT MR1988953293342483527
  • McNealJERedwineEAFreihaFSStameyTAZonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spreadAm J Surg Pathol198812128979063202246
  • SfanosKSDe MarzoAMProstate cancer and inflammation: the evidenceHistopathology201260119921522212087
  • ChughtaiBLeeRTeAKaplanSRole of inflammation in benign prostatic hyperplasiaRev Urol201113314715022110398
  • WagenlehnerFMElkahwajiJEAlgabaFThe role of inflammation and infection in the pathogenesis of prostate carcinomaBJU Int2007100473373717662075
  • OmabeMEzeaniMInfection, inflammation and prostate carcinogenesisInfect Genet Evol20111161195119821397049
  • De MarzoAMNakaiYNelsonWGInflammation, atrophy, and prostate carcinogenesisUrol Oncol200725539840017826659
  • De MarzoAMPlatzEASutcliffeSInflammation in prostate carcinogenesisNat Rev Cancer20077425626917384581
  • AmesBNGoldLSWillettWCThe causes and prevention of cancerProc Natl Acad Sci U S A19959212525852657777494
  • GiovannucciEMedical history and etiology of prostate cancerEpidemiol Rev200123115916211588842
  • AlbiniASpornMBThe tumour microenvironment as a target for chemopreventionNat Rev Cancer20077213914717218951
  • RobertGSalagierskiMSchalkenJAde la TailleAInflammation and benign prostatic hyperplasia: cause or consequence?Prog Urol2010206402407 French20538203
  • SchattemanPHHoekxLWyndaeleJJJeurisWVan MarckEInflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA densityEur Urol200037440441210765070
  • FibbiBPennaGMorelliAAdoriniLMaggiMChronic inflammation in the pathogenesis of benign prostatic hyperplasiaInt J Androl201033347548819508330
  • NickelJCRoehrbornCGO’LearyMPBostwickDGSomervilleMCRittmasterRSExamination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trialJ Urol20071783 Pt 189690017632164
  • NickelJCRoehrbornCGO’LearyMPBostwickDGSomervilleMCRittmasterRSThe relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trialEur Urol20085461379138418036719
  • RobertGDescazeaudANicolaiewNInflammation in benign prostatic hyperplasia: a 282 patients’ immunohistochemical analysisProstate200969161774178019670242
  • De MarzoAMMarchiVLEpsteinJINelsonWGProliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesisAm J Pathol199915561985199210595928
  • NelsonWGDe MarzoAMDeWeeseTLIsaacsWBThe role of inflammation in the pathogenesis of prostate cancerJ Urol20041725 Pt 2S6S1115535435
  • PalapattuGSSutcliffeSBastianPJProstate carcinogenesis and inflammation: emerging insightsCarcinogenesis20052671170118115498784
  • De MarzoAMMeekerAKZhaSHuman prostate cancer precursors and pathobiologyUrology2003625 Suppl 1556214607218
  • NelsonWGDe MarzoAMIsaacsWBProstate cancerN Engl J Med2003349436638112878745
  • De MarzoAMNelsonWGIsaacsWBEpsteinJIPathological and molecular aspects of prostate cancerLancet2003361936195596412648986
  • KleinEASilvermanRInflammation, infection, and prostate cancerCurr Opin Urol200818331531918382242
  • SutcliffeSSexually transmitted infections and risk of prostate cancer: review of historical and emerging hypothesesFuture Oncol2010681289131120799875
  • PelouzePSGonorrhea in the Male and Female: A Book for PractitionersPhiladelphia, PAWB Saunders1935
  • HandsfeldHHLipmanTOHarnischJPTroncaEHolmesKKAsymptomatic gonorrhea in men. Diagnosis, natural course, prevalence and significanceN Engl J Med197429031171234202519
  • PolettiFMediciMCAlinoviAIsolation of Chlamydia trachomatis from the prostatic cells in patients affected by nonacute abacterial prostatitisJ Urol198513446916934032572
  • GardnerWAJrCulbersonDEBennettBDTrichomonas vaginalis in the prostate glandArch Pathol Lab Med198611054304322421689
  • ThomsonLSyphilis of the prostateAm J Syphilis19204323341
  • BushmanWEtiology of ProstatitisLeporHProstatic DiseasesPhiladelphia, PAWB Saunders2000550557
  • StricklerHDGoedertJJSexual behavior and evidence for an infectious cause of prostate cancerEpidemiol Rev200123114415111588840
  • ZambranoAKalantariMSimoneauAJensenJLVillarrealLPDetection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infectionsProstate200253426327612430138
  • SamantaMHarkinsLKlemmKBrittWJCobbsCSHigh prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinomaJ Urol20031703998100212913758
  • KirbyRSLoweDBultitudeMIShuttleworthKEIntra-prostatic urinary reflux: an aetiological factor in abacterial prostatitisBr J Urol19825467297317150931
  • IsaacsJTProstatic structure and function in relation to the etiology of prostatic cancerProstate1983443513666866850
  • MartinonFPetrilliVMayorATardivelATschoppJGout-associated uric acid crystals activate the NALP3 inflammasomeNature2006440708123724116407889
  • DrachenbergCBPapadimitriouJCProstatic corpora amylacea and crystalloids: similarities and differences on ultrastructural and histochemical studiesJ Submicrosc Cytol Pathol19962821411508964038
  • SugimuraTWakabayashiKNakagamaHNagaoMHeterocyclic amines: mutagens/carcinogens produced during cooking of meat and fishCancer Sci200495429029915072585
  • KnizeMGFeltonJSFormation and human risk of carcinogenic heterocyclic amines formed from natural precursors in meatNutr Rev200563515816515971410
  • BorowskyADDingleyKHUbickETurteltaubKWCardiffRDDevere-WhiteRInflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat modelNeoplasia20068970871516984728
  • CoffeyDSSimilarities of prostate and breast cancer: evolution, diet, and estrogensUrology2001574 Suppl 1313811295592
  • HarkonenPLMakelaSIRole of estrogens in development of prostate cancerJ Steroid Biochem Mol Biol200492429730515663993
  • GilleranJPPutzODeJongMThe role of prolactin in the prostatic inflammatory response to neonatal estrogenEndocrinology200314452046205412697713
  • HuangLPuYAlamSBirchLPrinsGSEstrogenic regulation of signaling pathways and homeobox genes during rat prostate developmentJ Androl200425333033715064308
  • NaslundMJStrandbergJDCoffeyDSThe role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitisJ Urol19881405104910533172358
  • HuangLPuYAlamSBirchLPrinsGSThe role of Fgf10 signaling in branching morphogenesis and gene expression of the rat prostate gland: lobe-specific suppression by neonatal estrogensDev Biol2005278239641415680359
  • PrinsGSBirchLCouseJFChoiIKatzenellenbogenBKorachKSEstrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor α: studies with αERKO and βERKO miceCancer Res200161166089609711507058
  • PonniahSArahIAlexanderRBPSA is a candidate self-antigen in autoimmune chronic prostatitis/chronic pelvic pain syndromeProstate2000441495410861757
  • BrigantiACapitanioUSuardiNBenign prostatic hyperplasia and its aetiologiesEur Urol Suppl2009813865871
  • AbdollahFBrigantiASuardiNMetabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and preventionKorean J Urol201152850751621927696
  • RobertGDescazeaudAAlloryYVacherotFde la TailleAShould we investigate prostatic inflammation for the management of benign prostatic hyperplasia?Eur Urol Suppl2009813879886
  • KramerGMittereggerDMarbergerMIs benign prostatic hyperplasia (BPH) an inflammatory disease?Eur Urol20075151202121617182170
  • JahnischHFusselSKiesslingADendritic cell-based immunotherapy for prostate cancerClin Dev Immunol2010201051749321076523
  • KramerGMarbergerMCould inflammation be a key component in the progression of benign prostatic hyperplasia?Curr Opin Urol2006161252916385197
  • SteinerGENewmanMEPaiklDExpression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostateProstate200356317118212772186
  • SteinerGEStixUHandisuryaACytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissueLab Invest20038381131114612920242
  • CarusoCBalistreriCRCandoreGPolymorphisms of pro-inflammatory genes and prostate cancer risk: a pharmacogenomic approachCancer Immunol Immunother200958121919193319221747
  • WangLYangJRYangJYLiuZTChronic inflammation in benign prostatic hyperplasia: implications for therapyMed Hypotheses20087051021102317935901
  • PennaGFibbiBAmuchasteguiSHuman benign prostatic hyperplasia stromal cells as inducers and targets of chronic immunemediated inflammationJ Immunol200918274056406419299703
  • DescazeaudAWeinbreckNRobertGTransforming growth factor β-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammationBJU Int20111082 Pt 2E23E2820840324
  • SutcliffeSSexually transmitted infections and risk of prostate cancer: review of historical and emerging hypothesesFuture Oncol2010681289131120799875
  • SutcliffeSPlatzEAInflammation and prostate cancer: a focus on infectionsCurr Urol Rep20089324324918765120
  • VastoSCarrubaGCandoreGItalianoEDi BonaDCarusoCInflammation and prostate cancerFuture Oncol20084563764518922121
  • DennisLKLynchCFTornerJCEpidemiologic association between prostatitis and prostate cancerUrology2002601788312100928
  • RobertsROBergstralhEJBassSELieberMMJacobsenSJProstatitis as a risk factor for prostate cancerEpidemiology2004151939914712152
  • CohenRJShannonBAMcNealJEShannonTGarrettKLPropionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution?J Urol200517361969197415879794
  • HayesRBPotternLMStricklerHSexual behaviour, STDs and risks for prostate cancerBr J Cancer200082371872510682688
  • StricklerHDGoedertJSexual behavior and evidence for an infectious cause of prostate cancerEpidemiol Rev200123114415111588840
  • DennisLKDawsonDVMeta-analysis of measures of sexual activity and prostate cancerEpidemiology2002131727911805589
  • TaylorMLMainousAG3rdWellsBJProstate cancer and sexually transmitted diseases: a meta-analysisFam Med200537750651215988645
  • RosenblattKAWicklundKGStanfordJLSexual factors and the risk of prostate cancerAm J Epidemiol2001153121152115811415949
  • HochreiterWWNadlerRBKochAEEvaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretionsUrology20005661025102911113752
  • FujitaKEwingCMSokollLJCytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammationProstate200868887288218361406
  • VoronovEShouvalDSKrelinYIL-1 is required for tumor invasiveness and angiogenesisProc Natl Acad Sci U S A200310052645265012598651
  • CuligZPuhrMInterleukin-6: a multifunctional targetable cytokine in human prostate cancerMol Cell Endocrinol20123601–2525821664423
  • MalinowskaKNeuwirtHCavarrettaITInterleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptorEndocr Relat Cancer200916115516919011039
  • CuligZSteinerHBartschGHobischAInterleukin-6 regulation of prostate cancer cell growthJ Cell Biochem200595349750515838876
  • MichalakiVSyrigosKCharlesPWaxmanJSerum levels of IL-6 and TNF-α correlate with clinicopathological features and patient survival in patients with prostate cancerBr J Cancer200490122312231615150588
  • NumasakiMFukushiJOnoMInterleukin-17 promotes angiogenesis and tumor growthBlood200310172620262712411307
  • InoueKSlatonJWEveBYInterleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancerClin Cancer Res2000652104211910815938
  • UeharaHTroncosoPJohnstonDExpression of interleukin-8 gene in radical prostatectomy specimens is associated with advanced pathologic stageProstate2005641404915651067
  • ScottKAArnottCHRobinsonSCTNF-α regulates epithelial expression of MMP-9 and integrin αvβ6 during tumour promotion. A role for TNF-α in keratinocyte migration?Oncogene200423416954696615273742
  • ThomasGJLewisMPHartIRMarshallJFSpeightPMαvβ6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9Int J Cancer200192564165011340566
  • ParkJILeeMGChoKTransforming growth factor-β1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-κB, JNK, and Ras signaling pathwaysOncogene200322284314433212853969
  • LuTBurdelyaLGSwiatkowskiSMSecreted transforming growth factor β2 activates NF-κB, blocks apoptosis, and is essential for the survival of some tumor cellsProc Natl Acad Sci U S A2004101187112711715118089
  • LuSDongZCharacterization of TGF-β-regulated interleukin-8 expression in human prostate cancer cellsProstate2006669996100416541418
  • LuYCaiZXiaoGLiuYCCR2 expression correlates with prostate cancer progressionJ Cell Biochem2007101367668517216598
  • VadayGGPeehlDMKadamPALawrenceDMExpression of CCL5 (RANTES) and CCR5 in prostate cancerProstate200666212413416161154
  • KonigJESengeTAllhoffEPKonigWAnalysis of the inflammatory network in benign prostate hyperplasia and prostate cancerProstate200458212112914716737
  • HussainTGuptaSMukhtarHCyclooxygenase-2 and prostate carcinogenesisCancer Lett2003191212513512618325
  • FujitaHKoshidaKKellerETCyclooxygenase-2 promotes prostate cancer progressionProstate200253323224012386924
  • EdwardsJMukherjeeRMunroAFWellsACAlmushatatABartlettJMHer2 and COX2 expression in human prostate cancerEur J Cancer2004401505514687789
  • Aparicio GallegoGDiaz PradoSJimenez FonsecaPGarcia CampeloRCassinello EspinosaJAnton AparicioLMCyclooxygenase-2 (COX-2): a molecular target in prostate cancerClin Transl Oncol200791169470218055324
  • WangWBerghADamberJEChronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epitheliumProstate2004611607215287094
  • RisbridgerGPBiancoJJEllemSJMcPhersonSJOestrogens and prostate cancerEndocr Relat Cancer200310218719112790781
  • TamNNLeavIHoSMSex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble ratAm J Pathol200717141334134117717140
  • HarrisMTFeldbergRSLauKMLazarusNHCochraneDEExpression of proinflammatory genes during estrogen-induced inflammation of the rat prostateProstate2000441192510861753
  • PrinsGSHuangLBirchLPuYThe role of estrogens in normal and abnormal development of the prostate glandAnn N Y Acad Sci2006108911317261752